v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 17,056,313 $ 17,958,989
Other receivable from joint venture 0 400,000
Prepaid expenses and other current assets 254,652 47,371
Total Current Assets 17,310,965 18,406,360
Other Assets    
Patent costs 1,756,506 1,798,484
Total Assets 19,067,471 20,204,844
Current Liabilities    
Accounts payable and accrued liabilities 893,938 350,299
Total Current Liabilities 893,938 350,299
Stockholders' Equity    
Common stock, $0.001 par value, 8,333,333 authorized, 3,809,415 and 3,252,371 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 3,809 3,252
Additional paid-in capital 136,647,267 133,932,615
Accumulated deficit (118,480,938) (114,084,746)
Total Stockholders' Equity 18,173,533 19,854,545
Total Liabilities and Stockholders' Equity 19,067,471 20,204,844
Preferred Stock Series A [Member]    
Stockholders' Equity    
Preferred stock value 728 757
Series B Preferred Shares [Member]    
Stockholders' Equity    
Preferred stock value $ 2,667 $ 2,667

Source